Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy

Affiliations

• ¹ Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Wisconsin Institute for Medical Research, 1111 Highland Ave., Madison, WI, 53705, USA.
• ² Division of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
• ³ Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Wisconsin Institute for Medical Research, 1111 Highland Ave., Madison, WI, 53705, USA. dlwheeler@wisc.edu.